Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Mind the gap: venous thromboembolism prophylaxis in patients hospitalized with inflammatory bowel disease.

Literature DB >> 23179161

Mind the gap: venous thromboembolism prophylaxis in patients hospitalized with inflammatory bowel disease.

John I Allen.

Abstract

Entities: Disease Species

Mesh：

Substances：
Anticoagulants

Year: 2013 PMID： 23179161 DOI： 10.1007/s10620-012-2492-x

Source DB: PubMed Journal: Dig Dis Sci ISSN： 0163-2116 Impact factor: 3.199

× No keyword cloud information.

17 in total

1. Low-molecular-weight heparin and mortality in acutely ill medical patients.

Authors: Ajay K Kakkar; Claudio Cimminiello; Samuel Z Goldhaber; Rajiv Parakh; Chen Wang; Jean-François Bergmann
Journal: N Engl J Med Date: 2011-12-29 Impact factor: 91.245

Review 2. Quality of care for gastrointestinal conditions: a primer for gastroenterologists.

Authors: Michael D Kappelman; Spencer D Dorn; Erica Peterson; Thomas Runge; John I Allen
Journal: Am J Gastroenterol Date: 2011-07 Impact factor: 10.864

3. Aspirin for preventing the recurrence of venous thromboembolism.

Authors: Cecilia Becattini; Giancarlo Agnelli; Alessandro Schenone; Sabine Eichinger; Eugenio Bucherini; Mauro Silingardi; Marina Bianchi; Marco Moia; Walter Ageno; Maria Rita Vandelli; Elvira Grandone; Paolo Prandoni
Journal: N Engl J Med Date: 2012-05-24 Impact factor: 91.245

4. Vascular complications of inflammatory bowel disease.

Authors: R W Talbot; J Heppell; R R Dozois; R W Beart
Journal: Mayo Clin Proc Date: 1986-02 Impact factor: 7.616

5. Physicians' perceptions of risks and practices in venous thromboembolism prophylaxis in inflammatory bowel disease.

Authors: Justina J Sam; Charles N Bernstein; Roshan Razik; Reka Thanabalan; Geoffrey C Nguyen
Journal: Dig Dis Sci Date: 2012-10-07 Impact factor: 3.199

6. Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism.

Authors: Gottfried Novacek; Ansgar Weltermann; Anna Sobala; Herbert Tilg; Wolfgang Petritsch; Walter Reinisch; Andreas Mayer; Thomas Haas; Arthur Kaser; Thomas Feichtenschlager; Harry Fuchssteiner; Peter Knoflach; Harald Vogelsang; Wolfgang Miehsler; Reingard Platzer; Wolfgang Tillinger; Bernhard Jaritz; Alfons Schmid; Benedikt Blaha; Clemens Dejaco; Sabine Eichinger
Journal: Gastroenterology Date: 2010-06-12 Impact factor: 22.682

Mind the gap: venous thromboembolism prophylaxis in patients hospitalized with inflammatory bowel disease.

1. Low-molecular-weight heparin and mortality in acutely ill medical patients.

Review 2. Quality of care for gastrointestinal conditions: a primer for gastroenterologists.

3. Aspirin for preventing the recurrence of venous thromboembolism.

4. Vascular complications of inflammatory bowel disease.

5. Physicians' perceptions of risks and practices in venous thromboembolism prophylaxis in inflammatory bowel disease.

6. Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism.

7. Inflammatory bowel disease promotes venous thrombosis earlier in life.

Review 8. Inflammation and coagulation in inflammatory bowel disease: The clot thickens.

9. Estimated annual numbers of US acute-care hospital patients at risk for venous thromboembolism.

10. Venous thromboembolism: classification, risk factors, diagnosis, and management.

Review 1. Inflammatory bowel disease and thromboembolism.